Sophia Mao

Sophia Mao

Auto-generated profile, based on publicly available information

Sophia Mao

University of Illinois Chicago

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2026 in medRxiv
Verified
Preprint
Open access
KGKeshav Rajul Gandhi
Keshav Rajul Gandhi
SMSophia Mao
Sophia Mao
ETEric Tatara
Eric Tatara
JJonathan Ozik
Jonathan Ozik
BBBasmattee Boodram
Basmattee Boodram
HDHarel Dahari
Harel Dahari
Background and Aims: The probability of hepatitis C virus (HCV) clearance is mediated by an interaction between numerous factors. However, variation in spontaneous HCV clearance was previously modeled using relatively simple approaches with fixed probabilities by sex. Here, we developed a literature-informed clearance algorithm that considers age, sex, interferon lambda 4 (IFNL4) genotype, and infection history to model the probability of HCV clearance in vulnerable populations, such as people who inject drugs (PWID), and in controlled human infection (CHI) models for future HCV vaccines. Methods: We modeled HCV clearance probabilities for three infection-history pathways: first infection, reinfection after spontaneous clearance, and reinfection after direct-acting antiviral (DAA) cure. Logistic and cumulative-hazard equations assigned person-specific clearance probabilities in the first two pathways. The post-DAA pathway used fixed clearance probabilities. We tested the algorithm using HepCEP (Hepatitis C Elimination in PWID), an agent-based simulator. Results: First-infection clearance probabilities ranged from 0.13 to 0.51 across eight age, sex, and IFNL4 genotype subgroups. Clearance probabilities for reinfection after spontaneous clearance ranged from 0.20 to 0.80 at literature point estimates. Across 100 runs, the mean assigned clearance probabilities were 0.27 for first infections and 0.52 for reinfections after spontaneous clearance, compared with literature inputs of 0.26 and 0.52, respectively. Probabilities varied across subgroups and runs. Conclusion: Simulations reproduced the algorithm's intended clearance heterogeneity and uncertainty by age, sex, IFNL4 genotype, and infection history, which may support models of HCV elimination in vulnerable populations and CHI model development for future HCV vaccines.